Abstract
Bone marrow-derived endothelial progenitor cells (EPCs) play a key role in the maintenance of endothelial homeostasis and endothelial repair at areas of vascular damage. The quantification of EPCs in peripheral blood by flow cytometry is a strategy to assess this reparative capacity. The number of circulating EPCs is inversely correlated with the number of cardiovascular risk factors and to the occurrence of cardiovascular events. Therefore, monitoring EPCs levels may provide an accurate assessment of susceptibility to cardiovascular injury, greatly improving risk stratification of patients with high cardiovascular risk, such as those with an acute myocardial infarction. However, there are many issues in the field of EPC identification and quantification that remain unsolved. In fact, there have been conflicting protocols used to the phenotypic identification of EPCs and there is still no consensual immunophenotypical profile that corresponds exactly to EPCs. In this paper we aim to give an overview on EPCs-mediated vascular repair with special focus on acute coronary syndromes and to discuss the different phenotypic profiles that have been used to identify and quantify circulating EPCs in several clinical studies. Finally, we will synthesize evidence on the prognostic role of EPCs in patients with high cardiovascular risk.
Similar content being viewed by others
References
Kong, D., Melo, L. G., Gnecchi, M., et al. (2004). Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation, 110(14), 2039–2046.
Asahara, T., Masuda, H., Takahashi, T., et al. (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research, 85(3), 221–228.
Asahara, T., Murohara, T., Sullivan, A., et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964–967.
Schmidt-Lucke, C., Rossig, L., Fichtlscherer, S., et al. (2005). Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation, 111(22), 2981–2987.
Aragona, C. O., Imbalzano, E., Mamone, F., et al. (2016). Endothelial progenitor cells for diagnosis and prognosis in cardiovascular disease. Stem Cells International, 2016, 8043792.
Capobianco, S., Chennamaneni, V., Mittal, M., Zhang, N., & Zhang, C. (2010). Endothelial progenitor cells as factors in neovascularization and endothelial repair. World Journal of Cardiology, 2(12), 411–420.
Yoder, M. C. (2013). Endothelial progenitor cell: a blood cell by many other names may serve similar functions. Journal of Molecular Medicine (Berlin, Germany), 91(3), 285–295.
Negro, R., Greco, E. L., & Greco, G. (2017). Active stromal cell-derived factor 1α and endothelial progenitor cells are equally increased by alogliptin in good and poor diabetes control. Clinical Medicine Insights: Endocrinology and Diabetes, 10, 1179551417743980. https://doi.org/10.1177/1179551417743980.
Massa, M., Rosti, V., Ferrario, M., et al. (2005). Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood, 105(1), 199–206.
Werner, N., & Nickenig, G. (2006). Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arteriosclerosis, Thrombosis, and Vascular Biology, 26(2), 257–266.
Wojakowski, W., Tendera, M., Michalowska, A., et al. (2004). Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation, 110(20), 3213–3220.
Jernberg, T., Hasvold, P., Henriksson, M., Hjelm, H., Thuresson, M., & Janzon, M. (2015). Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. European Heart Journal, 36(19), 1163–1170.
Rigato, M., Avogaro, A., & Fadini, G. P. (2016). Levels of circulating progenitor cells, cardiovascular outcomes and death: a meta-analysis of prospective observational studies. Circulation Research, 118(12), 1930–1939.
Cuadrado-Godia, E., Regueiro, A., Nunez, J., et al. (2015). Endothelial progenitor cells predict cardiovascular events after atherothrombotic stroke and acute myocardial infarction. A PROCELL substudy. PloS One, 10(9), e0132415.
Regueiro, A., Cuadrado-Godia, E., Bueno-Beti, C., et al. (2015). Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: time-course after acute myocardial infarction and stroke. Journal of Molecular and Cellular Cardiology, 80, 146–155.
Jimenez-Navarro, M. F., Caballero-Borrego, J., Rodriguez-Losada, N., et al. (2011). Influence of preinfarction angina on the release kinetics of endothelial progenitor cells and cytokines during the week after infarction. European Journal of Clinical Investigation, 41(11), 1220–1226.
Antonio, N., Fernandes, R., Soares, A., et al. (2014). Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. Cardiovascular Diabetology, 13, 101.
Numaguchi, Y., Sone, T., Okumura, K., et al. (2006). The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation, 114(1 Suppl), I114–I119.
Porto, I., De Maria, G. L., Leone, A. M., et al. (2013). Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. American Journal of Cardiology, 112(6), 782–791.
Porto, I., Leone, A. M., De Maria, G. L., et al. (2011). Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study. Atherosclerosis, 216(2), 355–358.
Schmidt-Lucke, C., Fichtlscherer, S., Aicher, A., et al. (2010). Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PloS One, 5(11), e13790.
Povsic, T. J., Najjar, S. S., Prather, K., et al. (2013). EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy. Journal of Thrombosis and Thrombolysis, 36(4), 375–383.
Werner, N., Kosiol, S., Schiegl, T., et al. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. New England Journal of Medicine, 353(10), 999–1007.
Werner, N., Wassmann, S., Ahlers, P., et al. (2007). Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Research in Cardiology, 102(6), 565–571.
Porto, I., Di Vito, L., De Maria, G. L., et al. (2009). Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome. American Journal of Cardiology, 103(11), 1500–1505.
Mozid, A. M., Jones, D., Arnous, S., et al. (2013). The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease. Stem Cells and Development, 22(2), 216–223.
Lev, E. I., Kleiman, N. S., Birnbaum, Y., Harris, D., Korbling, M., & Estrov, Z. (2005). Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. Journal of Vascular Research, 42(5), 408–414.
Kuliczkowski, W., Derzhko, R., Prajs, I., Podolak-Dawidziak, M., & Serebruany, V. L. (2012). Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions. American Journal of Therapeutics, 19(1), 44–50.
Nolan, D. J., Ciarrocchi, A., Mellick, A. S., et al. (2007). Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes & Development, 21(12), 1546–1558.
Gao, D., & Mittal, V. (2009). The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends in Molecular Medicine, 15(8), 333–343.
Kim, J. Y., Song, S. H., Kim, K. L., et al. (2010). Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Cell Transplantation, 19(12), 1635–1644.
Um, J., Jung, N., Chin, S., Cho, Y., Choi, S., & Park, K. S. (2016). Substance P enhances EPC mobilization for accelerated wound healing. Wound Repair and Regeneration, 24(2), 402–410.
Shintani, S., Murohara, T., Ikeda, H., et al. (2001). Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation, 103(23), 2776–2779.
Murayama, T., Tepper, O. M., Silver, M., et al. (2002). Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Experimental Hematology, 30(8), 967–972.
Risau, W., & Flamme, I. (1995). Vasculogenesis. Annual Review of Cell and Developmental Biology, 11, 73–91.
Choi, K., Kennedy, M., Kazarov, A., Papadimitriou, J. C., & Keller, G. (1998). A common precursor for hematopoietic and endothelial cells. Development, 125(4), 725–732.
Carmeliet, P. (2000). Mechanisms of angiogenesis and arteriogenesis. Nature Medicine, 6(4), 389–395.
Risau, W. (1997). Mechanisms of angiogenesis. Nature, 386(6626), 671–674.
Ribatti, D., Vacca, A., Nico, B., Roncali, L., & Dammacco, F. (2001). Postnatal vasculogenesis. Mechanisms of Development, 100(2), 157–163.
Zengin, E., Chalajour, F., Gehling, U. M., et al. (2006). Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development, 133(8), 1543–1551.
Gunsilius, E., Duba, H. C., Petzer, A. L., et al. (2000). Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet, 355(9216), 1688–1691.
Rosenzweig, A. (2003). Endothelial progenitor cells. New England Journal of Medicine, 348(7), 581–582.
Imanishi, T., Tsujioka, H., & Akasaka, T. (2008). Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Current Cardiology Reviews, 4(4), 275–286.
Heissig, B., Hattori, K., Dias, S., et al. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 109(5), 625–637.
Dar, A., Kollet, O., & Lapidot, T. (2006). Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Experimental Hematology, 34(8), 967–975.
Briasoulis, A., Tousoulis, D., Antoniades, C., Papageorgiou, N., & Stefanadis, C. (2011). The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovascular Therapeutics, 29(2), 125–139.
Lapidot, T., & Petit, I. (2002). Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Experimental Hematology, 30(9), 973–981.
Takahashi, T., Kalka, C., Masuda, H., et al. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine, 5(4), 434–438.
Balaji, S., King, A., Crombleholme, T. M., & Keswani, S. G. (2013). The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing. Advances in Wound Care (New Rochelle), 2(6), 283–295.
De Falco, E., Porcelli, D., Torella, A. R., et al. (2004). SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood, 104(12), 3472–3482.
Asahara, T., Takahashi, T., Masuda, H., et al. (1999). VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO Journal, 18(14), 3964–3972.
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., et al. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Medicine, 10(8), 858–864.
Krock, B. L., Skuli, N., & Simon, M. C. (2011). Hypoxia-induced angiogenesis: good and evil. Genes & Cancer, 2(12), 1117–1133.
Aicher, A., Zeiher, A. M., & Dimmeler, S. (2005). Mobilizing endothelial progenitor cells. Hypertension, 45(3), 321–325.
Huang, P. H., Chen, Y. H., Wang, C. H., et al. (2009). Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(8), 1179–1184.
Petit, I., Jin, D., & Rafii, S. (2007). The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends in Immunology, 28(7), 299–307.
Fortunato, O., Spinetti, G., Specchia, C., Cangiano, E., Valgimigli, M., & Madeddu, P. (2013). Migratory activity of circulating progenitor cells and serum SDF-1alpha predict adverse events in patients with myocardial infarction. Cardiovascular Research, 100(2), 192–200.
Tilling, L., Chowienczyk, P., & Clapp, B. (2009). Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells. British Journal of Clinical Pharmacology, 68(4), 484–492.
Gill, M., Dias, S., Hattori, K., et al. (2001). Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circulation Research, 88(2), 167–174.
Xu, J., Liu, X., Jiang, Y., et al. (2008). MAPK/ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. Journal of Cellular and Molecular Medicine, 12(6a), 2395–2406.
Cheng, Y., Jiang, S., Hu, R., & Lv, L. (2013). Potential mechanism for endothelial progenitor cell therapy in acute myocardial infarction: activation of VEGF- PI3K/Akte-NOS pathway. Annals of Clinical and Laboratory Science, 43(4), 395–401.
Wu, Y., Potempa, L. A., El Kebir, D., & Filep, J. G. (2015). C-reactive protein and inflammation: conformational changes affect function. Biological Chemistry, 396(11), 1181–1197.
Peplow, P. V. (2014). Influence of growth factors and cytokines on angiogenic function of endothelial progenitor cells: a review of in vitro human studies. Growth Factors, 32(3–4), 83–116.
Du, F., Zhou, J., Gong, R., et al. (2012). Endothelial progenitor cells in atherosclerosis. Frontiers in Bioscience (Landmark Edition), 17, 2327–2349.
Gross, A., Schoendube, J., Zimmermann, S., Steeb, M., Zengerle, R., & Koltay, P. (2015). Technologies for single-cell isolation. International Journal of Molecular Sciences, 16(8), 16897–16919.
Fadini, G. P., Baesso, I., Albiero, M., Sartore, S., Agostini, C., & Avogaro, A. (2008). Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis, 197(2), 496–503.
Spano, M., & Evenson, D. P. (1993). Flow cytometric analysis for reproductive biology. Biologie Cellulaire, 78(1–2), 53–62.
Ibrahim, S. F., & van den Engh, G. (2007). Flow cytometry and cell sorting. Advances in Biochemical Engineering/Biotechnology, 106, 19–39.
Bellik, L., Ledda, F., & Parenti, A. (2005). Morphological and phenotypical characterization of human endothelial progenitor cells in an early stage of differentiation. FEBS Letters, 579(12), 2731–2736.
Khan, S. S., Solomon, M. A., & McCoy Jr., J. P. (2005). Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry, Part B: Clinical Cytometry, 64(1), 1–8.
Yoder, M. C. (2012). Human endothelial progenitor cells. Cold Spring Harbor Perspectives in Medicine, 2(7), a006692.
Sirker, A. A., Astroulakis, Z. M., & Hill, J. M. (2009). Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. Clinical Science (London, England: 1979), 116(4), 283–299.
Fadini, G. P., Losordo, D., & Dimmeler, S. (2012). Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circulation Research, 110(4), 624–637.
Lin, L. Y., Huang, C. C., Chen, J. S., et al. (2014). Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study. Cardiovascular Diabetology, 13, 111.
Yin, A. H., Miraglia, S., Zanjani, E. D., et al. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90(12), 5002–5012.
Krause, D. S., Fackler, M. J., Civin, C. I., & May, W. S. (1996). CD34: structure, biology, and clinical utility. Blood, 87(1), 1–13.
Andrews, R. G., Singer, J. W., & Bernstein, I. D. (1986). Monoclonal antibody 12–8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood, 67(3), 842–845.
Sidney, L. E., Branch, M. J., Dunphy, S. E., Dua, H. S., & Hopkinson, A. (2014). Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells, 32(6), 1380–1389.
Lin, G., Finger, E., & Gutierrez-Ramos, J. C. (1995). Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. European Journal of Immunology, 25(6), 1508–1516.
Siemerink, M. J., Klaassen, I., Vogels, I. M., Griffioen, A. W., Van Noorden, C. J., & Schlingemann, R. O. (2012). CD34 marks angiogenic tip cells in human vascular endothelial cell cultures. Angiogenesis, 15(1), 151–163.
Stauffer, B. L., Maceneaney, O. J., Kushner, E. J., et al. (2008). Gender and endothelial progenitor cell number in middle-aged adults. Artery Research, 2(4), 156–160.
Fadini, G. P., Coracina, A., Baesso, I., et al. (2006). Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke, 37(9), 2277–2282.
Peichev, M., Naiyer, A. J., Pereira, D., et al. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 95(3), 952–958.
Friedrich, E. B., Walenta, K., Scharlau, J., Nickenig, G., & Werner, N. (2006). CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circulation Research, 98(3), e20–e25.
Powell, T. M., Paul, J. D., Hill, J. M., et al. (2005). Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(2), 296–301.
Schatteman, G. C., & Awad, O. (2004). Hemangioblasts, angioblasts, and adult endothelial cell progenitors. Anatomical record part a: Discoveries in molecular, Cellular, and Evolutionary Biology, 276(1), 13–21.
Chao, H., & Hirschi, K. K. (2010). Hemato-vascular origins of endothelial progenitor cells? Microvascular Research, 79(3), 169–173.
Estes, M. L., Mund, J. A., Mead, L. E., et al. (2010). Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential. Cytometry. Part A : the Journal of the International Society for Analytical Cytology, 77(9), 831–839.
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7(4), 430–436.
Li, T. S., Hamano, K., Nishida, M., et al. (2003). CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation. American Journal of Physiology: Heart and Circulatory Physiology, 285(3), H931–H937.
Li, T. S., Hayashi, M., Liu, Z. L., et al. (2004). Low angiogenic potency induced by the implantation of ex vivo expanded CD117(+) stem cells. American Journal of Physiology: Heart and Circulatory Physiology, 286(4), H1236–H1241.
Duff, S. E., Li, C., Garland, J. M., & Kumar, S. (2003). CD105 is important for angiogenesis: Evidence and potential applications. FASEB Journal, 17(9), 984–992.
Yu, D. C., Chen, J., & Ding, Y. T. (2010). Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the ‘niche’ of endothelial progenitor cells. International Journal of Molecular Sciences, 11(8), 2901–2909.
Li, C., Hampson, I. N., Hampson, L., Kumar, P., Bernabeu, C., & Kumar, S. (2000). CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB Journal, 14(1), 55–64.
Hager, G., Holnthoner, W., Wolbank, S., et al. (2013). Three specific antigens to isolate endothelial progenitor cells from human liposuction material. Cytotherapy, 15(11), 1426–1435.
Hill, J. M., Zalos, G., Halcox, J. P., et al. (2003). Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New England Journal of Medicine, 348(7), 593–600.
Jialal, I., Devaraj, S., Singh, U., & Huet, B. A. (2010). Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk. Atherosclerosis, 211(1), 297–302.
Wu, Y. T., Li, J. X., Liu, S., et al. (2012). A novel and feasible way to cultivate and purify endothelial progenitor cells from bone marrow of children with congenital heart diseases. Chinese Medical Journal (Engl), 125(11), 1903–1907.
Hur, J., Yoon, C. H., Kim, H. S., et al. (2004). Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(2), 288–293.
Mauge, L., Sabatier, F., Boutouyrie, P., et al. (2014). Forearm ischemia decreases endothelial colony-forming cell angiogenic potential. Cytotherapy, 16(2), 213–224.
Wang, C. H., Huang, P. H., Chen, J. W., et al. (2013). Clinical application of endothelial progenitor cell: are we ready? Acta Cardiologica Sinica, 29(6), 479–487.
Yoder, M. C., Mead, L. E., Prater, D., et al. (2007). Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 109(5), 1801–1809.
Ingram, D. A., Mead, L. E., Tanaka, H., et al. (2004). Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood, 104(9), 2752–2760.
Lekakis, J., Abraham, P., Balbarini, A., et al. (2011). Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on peripheral circulation. European Journal of Cardiovascular Prevention and Rehabilitation, 18(6), 775–789.
Huizer, K., Mustafa, D. A. M., Spelt, J. C., Kros, J. M., & Sacchetti, A. (2017). Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol. PloS One, 12(9), e0184895.
Brixius, K., Funcke, F., Graf, C., & Bloch, W. (2006). Endothelial progenitor cells: a new target for the prevention of cardiovascular diseases. European Journal of Cardiovascular Prevention and Rehabilitation, 13(5), 705–710.
Shantsila, E., Watson, T., Tse, H. F., & Lip, G. Y. (2007). Endothelial colony forming units: are they a reliable marker of endothelial progenitor cell numbers? Annals of Medicine, 39(6), 474–479.
Chu, K., Jung, K. H., Lee, S. T., et al. (2008). Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke. Stroke, 39(5), 1441–1447.
Torsney, E., Mandal, K., Halliday, A., Jahangiri, M., & Xu, Q. (2007). Characterisation of progenitor cells in human atherosclerotic vessels. Atherosclerosis, 191(2), 259–264.
Ciulla, M. M., Giorgetti, A., Silvestris, I., et al. (2006). Endothelial colony forming capacity is related to C-reactive protein levels in healthy subjects. Current Neurovascular Research, 3(2), 99–106.
Wang, X., & Connolly, T. M. (2010). Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. Advances in Clinical Chemistry, 50, 1–22.
Chironi, G., Walch, L., Pernollet, M. G., et al. (2007). Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis, 191(1), 115–120.
Hughes, A. D., Coady, E., Raynor, S., et al. (2007). Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis. European Journal of Clinical Investigation, 37(1), 35–41.
Libby, P., Ridker, P. M., & Hansson, G. K. (2011). Progress and challenges in translating the biology of atherosclerosis. Nature, 473(7347), 317–325.
Anderson, J. L., & Morrow, D. A. (2017). Acute myocardial infarction. New England Journal of Medicine, 376(21), 2053–2064.
Kotecha, T., & Rakhit, R. D. (2016). Acute coronary syndromes. Clinical Medicine (London, England), 16(Suppl 6), s43–s48.
Paxinos, G., & Katritsis, D. G. (2012). Current therapy of non-ST-elevation acute coronary syndromes. Hellenic Journal of Cardiology Hellenike Kardiologike Epitheorese, 53(1), 63–71.
Seiler, C. (2010). The human coronary collateral circulation. European Journal of Clinical Investigation, 40(5), 465–476.
Habib, G. B., Heibig, J., Forman, S. A., et al. (1991). Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation, 83(3), 739–746.
Acknowledgments
It is our privilege to express our sincere acknowledgments to all who helped us to successfully complete this manuscript. The authors received no specific funding for this work.
Contributions
The first draft was written by Leal V. Silva S designed the work. All authors critically revised the manuscript. All gave final approval and agree to be accountable for all aspects of work ensuring integrity and accuracy.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no potential conflicts of interest.
Rights and permissions
About this article
Cite this article
Leal, V., Ribeiro, C.F., Oliveiros, B. et al. Intrinsic Vascular Repair by Endothelial Progenitor Cells in Acute Coronary Syndromes: an Update Overview. Stem Cell Rev and Rep 15, 35–47 (2019). https://doi.org/10.1007/s12015-018-9857-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-018-9857-2